arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 1/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Antivirals for early treatment of COVID-19? Molnupiravir (LAGEVRIO), nirmatrelvir plus ritonavir (PAXLOVID) and remdesivir (VEKLURY)

    THERAPY FROM A CRITICAL VIEWPOINT

    Perioperative management of patients treated with coumarin anticoagulants – the PERIOP2 trial

    IN BRIEF

    SGLT-2 inhibitor ertugliflozin (STEGLATRO): “me-too” with a negative benefit-risk ratio
    free

    Migraine prophylaxis: direct comparison of the antibody erenumab (AIMOVIG) with topiramate (TOPAMAX, generics)

    About the background of a prophylactic “Dear Doctor Letter” on the levothyroxine drug BERLTHYROX

    SIDE EFFECTS

    FDA: caries and loss of teeth with sublingual buprenorphine (SUBUTEX, generics)

    e a-t ON THE INTERNET

    Cytisine (ASMOKEN) for smoking cessation

    Remdesivir (VEKLURY) for oxygen dependent COVID-19 pneumonia

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!